v3.22.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue $ 32 $ 4,402
Costs of goods sold 0 6,745
Gross margin 32 (2,343)
Operating expenses:    
Research and development 2,941 3,050
Selling, general, and administrative 3,180 4,258
Management fees 0 30
Total operating expenses 6,121 7,338
Loss from operations (6,089) (9,681)
Interest, net (17) (346)
Non-operating expenses 487 (1)
Loss before income taxes (5,619) (10,028)
Income taxes 0 0
Net loss $ (5,619) $ (10,028)
Basic and diluted net loss per share $ (0.13) $ (0.27)
Weighted average shares outstanding - basic and diluted 42,020,090 37,136,338
Anti-dilutive stock options, restricted stock units, performance stock units, and common stock warrants 16,276,362 5,013,780

Source